TNNI3 and infection: Remarkably, remdesivir, which has been shown to have significant antiviral efficacy in hamsters, was able to inhibit serum cTnI levels at 4 dpi when compared to the infection control (Figure 3—figure supplement 1D; Cortinovis et al., 2021).